L-arginine for the treatment of centrally obese subjects: A pilot study

Ryan T. Hurt, Jon O. Ebbert, Darrell R. Schroeder, Ivana T. Croghan, Brent A. Bauer, Stephen A. McClave, John M. Miles, Craig J. McClain

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Background: Visceral adiposity has been linked to higher rates of cardiometabolic risk than other types of adiposity. Waist circumference (WC) is the best anthropomorphic surrogate of visceral adiposity. Reductions in central adiposity may decrease cardiovascular risk. Animal studies have demonstrated that L-arginine reduces visceral adiposity and fat mass. The primary aim of our study was to assess the efficacy of L-arginine for reducing central adiposity in nondiabetic obese subjects. Secondary aims were to assess the efficacy of L-arginine for decreasing body mass index (BMI), waist-to-hip ratio (WHR), and weight. Materials and Methods: Female subjects (n = 20) were included if they: were ≥ 18 years and ≤ 40 years of age, had a BMI of ≥ 30 and ≤ 40 kg/m2, had a WC ≥ 89 cm. Subjects received 3 g of L-arginine three times a day for 12 weeks and were counseled on lifestyle modification. Results: Overall, L-arginine was well tolerated with no clinically significant adverse events. Serum L-arginine levels were significantly increased from baseline at both 6 and 12 weeks (p < .05). WC (mean ± SD) decreased from 115.6 ± 12.7 cm at baseline to 109.2 ± 11.7 cm at 12 weeks (p = .0004). Weight (mean ± SD) decreased from 98.6 ± 19.7 kg at baseline to 95.7 ± 18.6 kg at 12 weeks (p = .015). Significant reductions from baseline were also observed in BMI and WHR. Conclusions: L-Arginine may be effective at reducing central adiposity in obese patients.

Original languageEnglish (US)
Pages (from-to)40-52
Number of pages13
JournalJournal of Dietary Supplements
Volume11
Issue number1
DOIs
StatePublished - Mar 1 2014

Keywords

  • L-arginine
  • Obesity
  • Supplement
  • Weight loss

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'L-arginine for the treatment of centrally obese subjects: A pilot study'. Together they form a unique fingerprint.

  • Cite this